MedPath

Evaluation of ctDNA as a prognostic marker in gastric cancer or adenocarcinomas of the gastroesophageal junction - a prospective observational study

Recruiting
Conditions
C16
Malignant neoplasm of stomach
Registration Number
DRKS00028259
Lead Sponsor
niversitätsklinikum Ulm
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

1. Patients with GEJ/stomach adenocarcinoma scheduled for curative-intent treatment by perioperative chemo(radio)therapy and surgery
2. Ability of subject to understand character and individual consequences of the clinical trial
3. Age = 18 years
4. Written informed consent

Exclusion Criteria

1. Participation in an interventional trial with interference of procedures and/or outcome of this study
2. Patients with a legal guardian

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The aim of this study is the evaluation of the prognostic value of serial ctDNA measurements in patients with GC/ACGEJ. Furthermore, the possibility to develop or adjust curative-intent treatment according to ctDNA results in these patients will be assessed.
Secondary Outcome Measures
NameTimeMethod
- Detection rate of ctDNA (before start of cancer treatment)<br>- ctDNA positivity at the respective time points<br>- Disease-free survival defined as time from curative surgery until disease recurrence or death<br>- Distant recurrence defined as disease recurrence after curative surgery at a different site than the primary tumor, e.g. liver, lung, peritoneal or bone metastases<br>- Local recurrence defines as histologically proven recurrent tumor at the anastomosis or the perianastomotic region<br>- Disease specific survival rate at two years after surgery defined as the percentage of patients, who have not died from GC/ACGEJ within two years of surgery. Patients, who died from other causes than GC/ACGEJ will not be counted in this measurement.
© Copyright 2025. All Rights Reserved by MedPath